{"id":"https://openalex.org/W4362413331","doi":"https://doi.org/10.1158/1078-0432.22487934","title":"Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma","display_name":"Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4362413331","doi":"https://doi.org/10.1158/1078-0432.22487934"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22487934","doi":"https://doi.org/10.1158/1078-0432.22487934","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487934","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22487934","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031062394","display_name":"Vandana Batra","orcid":"https://orcid.org/0000-0003-2963-4835","observed_orcids":["https://orcid.org/0000-0003-2963-4835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vandana Batra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2963-4835","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081696578","display_name":"Minu Samanta","orcid":"https://orcid.org/0000-0003-2357-8748","observed_orcids":["https://orcid.org/0000-0003-2357-8748"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minu Samanta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2357-8748","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071268972","display_name":"Mehran Makvandi","orcid":"https://orcid.org/0000-0002-6315-4942","observed_orcids":["https://orcid.org/0000-0002-6315-4942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehran Makvandi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6315-4942","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004648124","display_name":"David Groff","orcid":"https://orcid.org/0000-0001-6897-2656","observed_orcids":["https://orcid.org/0000-0001-6897-2656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Groff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6897-2656","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002348171","display_name":"Paul Martorano","orcid":"https://orcid.org/0000-0001-8824-0065","observed_orcids":["https://orcid.org/0000-0001-8824-0065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Martorano","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8824-0065","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022832293","display_name":"Jimmy Elias","orcid":"https://orcid.org/0000-0002-1775-0356","observed_orcids":["https://orcid.org/0000-0002-1775-0356"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jimmy Elias","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1775-0356","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050323685","display_name":"Pietro Ranieri","orcid":"https://orcid.org/0000-0002-3644-8558","observed_orcids":["https://orcid.org/0000-0002-3644-8558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Ranieri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3644-8558","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048910641","display_name":"Matthew Tsang","orcid":"https://orcid.org/0000-0002-2983-2914","observed_orcids":["https://orcid.org/0000-0002-2983-2914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Tsang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2983-2914","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082627212","display_name":"Catherine Hou","orcid":"https://orcid.org/0000-0001-8905-8492","observed_orcids":["https://orcid.org/0000-0001-8905-8492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Hou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8905-8492","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017202683","display_name":"Yimei Li","orcid":"https://orcid.org/0000-0001-9067-6992","observed_orcids":["https://orcid.org/0000-0001-9067-6992","https://orcid.org/0000-0002-7046-4316"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yimei Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9067-6992","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063084227","display_name":"Bruce Pawel","orcid":"https://orcid.org/0000-0001-7678-5324","observed_orcids":["https://orcid.org/0000-0001-7678-5324"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce Pawel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7678-5324","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042276874","display_name":"Daniel Mart\u00ednez","orcid":"https://orcid.org/0000-0002-4723-9989","observed_orcids":["https://orcid.org/0000-0002-4723-9989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Martinez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4723-9989","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003562375","display_name":"Ganesan Vaidyanathan","orcid":"https://orcid.org/0000-0003-3041-8275","observed_orcids":["https://orcid.org/0000-0003-3041-8275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ganesan Vaidyanathan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3041-8275","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050946249","display_name":"Sean Carlin","orcid":"https://orcid.org/0000-0002-5401-0648","observed_orcids":["https://orcid.org/0000-0002-5401-0648"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sean Carlin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5401-0648","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074054064","display_name":"Daniel A. Pryma","orcid":"https://orcid.org/0000-0001-8978-4419","observed_orcids":["https://orcid.org/0000-0001-8978-4419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel A. Pryma","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8978-4419","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005797590","display_name":"John M. Maris","orcid":"https://orcid.org/0000-0002-8088-7929","observed_orcids":["https://orcid.org/0000-0002-8088-7929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Maris","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8088-7929","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/astatine-211","display_name":"astatine-211","score":0.9070000052452087},{"id":"https://openalex.org/keywords/alpha-particle-therapy","display_name":"alpha therapy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/radiopharmaceutical-therapy","display_name":"radiopharmaceutical therapy","score":0.8539999723434448},{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C66385817","wikidata":"https://www.wikidata.org/wiki/Q103517","display_name":"Alpha particle","level":2,"score":0.4404958188533783},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.3689599931240082},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.30589616298675537},{"id":"https://openalex.org/C185544564","wikidata":"https://www.wikidata.org/wiki/Q81197","display_name":"Nuclear physics","level":1,"score":0.2109086513519287},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18732306361198425}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22487934","doi":"https://doi.org/10.1158/1078-0432.22487934","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487934","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22487934","doi":"https://doi.org/10.1158/1078-0432.22487934","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22487934","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361954151","https://openalex.org/W4286495536","https://openalex.org/W2282036774","https://openalex.org/W2741863434","https://openalex.org/W2563880051","https://openalex.org/W253161923","https://openalex.org/W2073017898","https://openalex.org/W1602336352","https://openalex.org/W7221002187","https://openalex.org/W4411418818"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"from":[2],"Preclinical":[3],"Development":[4],"of":[5],"[211At]meta-":[6],"astatobenzylguanidine":[7],"([211At]MABG)":[8],"as":[9],"an":[10],"Alpha":[11],"Particle":[12],"Radiopharmaceutical":[13],"Therapy":[14],"for":[15],"Neuroblastoma":[16]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2023-04-05T00:00:00"}